Extended adjuvant neratinib in HER2+/HR+ early breast cancer in clinical routine-final results from the multinational, prospective, observational study ELEANOR
- K Zaman (Author)
- D Lüftner (Author)
- N Harbeck (Author)
- U Breitenstein (Author)
- C Jackisch (Author)
- V Müller (Author)
- M Schmidt (Author)
- Balic, M. (Author)
- Rinnerthaler, G. (Author)
- M Schwitter (Author)
- D Wrobel (Author)
- D Guth (Author)
- M Zaiss (Author)
- J Terhaag (Author)
- L Perlova-Grif (Author)
- A Distelrath (Author)
- N Deuerling (Author)
- R Würstlein (Author)
- T Schinköthe (Author)
- C Vannier (Author)
- R Bartsch (Author)
Activity: Talk, presentation or poster › Poster